SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-013974
Filing Date
2020-12-29
Accepted
2020-12-29 17:00:16
Documents
14
Period of Report
2020-12-23
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cvm-20201231.htm   iXBRL 8-K 404141
  Complete submission text file 0001654954-20-013974.txt   540393

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cvm-20201231.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20201231_cal.xml EX-101.CAL 871
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20201231_def.xml EX-101.DEF 1870
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20201231_lab.xml EX-101.LAB 15867
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20201231_pre.xml EX-101.PRE 11580
7 EXTRACTED XBRL INSTANCE DOCUMENT cvm-20201231_htm.xml XML 4270
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 201423093
SIC: 2836 Biological Products, (No Diagnostic Substances)